<SEC-DOCUMENT>0001193125-23-140010.txt : 20230510
<SEC-HEADER>0001193125-23-140010.hdr.sgml : 20230510
<ACCEPTANCE-DATETIME>20230510070900
ACCESSION NUMBER:		0001193125-23-140010
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230510
DATE AS OF CHANGE:		20230510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alaunos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001107421
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841475642
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33038
		FILM NUMBER:		23904305

	BUSINESS ADDRESS:	
		STREET 1:		8030 EL RIO STREET
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054
		BUSINESS PHONE:		(346) 355-4099

	MAIL ADDRESS:	
		STREET 1:		8030 EL RIO STREET
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZIOPHARM ONCOLOGY INC
		DATE OF NAME CHANGE:	20050919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASYWEB INC
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d459099d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tcrt="http://alaunos.com/20230510" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-05-10_to_2023-05-10">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-05-10_to_2023-05-10">0001107421</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="tcrt-20230510.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-05-10_to_2023-05-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-10</xbrli:startDate> <xbrli:endDate>2023-05-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-05-10_to_2023-05-10">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt:datemonthdayyearen">May 10, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-05-10_to_2023-05-10">Alaunos Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-05-10_to_2023-05-10">001-33038</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-05-10_to_2023-05-10">84-1475642</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-05-10_to_2023-05-10">8030 El Rio Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-05-10_to_2023-05-10">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-05-10_to_2023-05-10">TX</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-05-10_to_2023-05-10">77054</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices, including zip code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-05-10_to_2023-05-10">(346)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-05-10_to_2023-05-10">355-4099</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-10_to_2023-05-10">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-10_to_2023-05-10">TCRT</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-05-10_to_2023-05-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;2.02 Results of Operations and Financial Condition. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;10, 2023, Alaunos Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial condition and results of operations for the three months ended March&#160;31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in this Item 2.02, including Exhibit 99.1, is being &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The information contained in this Item 2.02, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the&#160;Securities Act&#160;or into any filing or other document pursuant to the&#160;Exchange Act, except as otherwise expressly stated in any such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01 Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td style="width:90%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit&#160;No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d459099dex991.htm">Press Release of Alaunos Therapeutics, Inc., dated May&#160;10, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">Alaunos Therapeutics, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date. May&#160;10, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melinda Lackey</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name: Melinda Lackey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title: Senior Vice President, Legal</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d459099dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g459099g27q68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Alaunos Therapeutics Reports First Quarter 2023 Financial Results </U> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Actively enrolling patients and manufacturing cryopreserved products for
<FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 trial; expect to report interim data in the third quarter of 2023</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fully prepaid loan with Silicon Valley Bank; now a debt-free company</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Amended exclusive licensing agreement with Precigen, Inc., reflecting the Company&#146;s focus on its <FONT
STYLE="white-space:nowrap">TCR-T</FONT> programs and eliminating long-term financial obligations</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Company to host conference call today at 9:00 a.m. ET</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOUSTON, May</B><B></B><B>&nbsp;10, 2023</B> &#150; Alaunos Therapeutics, Inc. (&#147;Alaunos&#148; or the &#147;Company&#148;) (Nasdaq: TCRT), a leading <FONT
STYLE="white-space:nowrap">T-cell</FONT> receptor (TCR) cell therapy company advancing a clinical-stage pipeline of therapeutics for solid tumors, today announced financial results for the first quarter ended March&nbsp;31, 2023, and provided a
corporate update. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 trial continues to garner significant interest among
patients, physicians and investigators,&#148; said Kevin S. Boyle, Sr., Chief Executive Officer of Alaunos. &#147;We&#146;ve been actively enrolling patients and manufacturing cryopreserved products, and we expect to report interim clinical data in
the third quarter of this year. As we work to fully realize the long-term potential of our <FONT STYLE="white-space:nowrap">TCR-T</FONT> platform, we have simplified our corporate structure with the full prepayment of our loan with SVB and the
recent agreement with Precigen. We are now moving forward unencumbered by debt or these potential royalties as we seek to transform the treatment of solid tumors.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Recent Developments and Upcoming Milestones </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2</B><B> trial actively enrolling patients: </B>Alaunos continues to actively enroll patients in its <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 trial targeting KRAS, TP53
and EGFR driver mutations across six solid tumor indications. Early translational data from the first three patients treated in the program will be highlighted in a poster at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
taking place June <FONT STYLE="white-space:nowrap">2-6,</FONT> 2023. Alaunos currently expects to provide an interim data update on multiple new patients in the third quarter of this year as the Company advances the program towards Phase 2 readiness
with a recommended Phase 2 dose anticipated by year end 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufactured multiple cryopreserved products: </B>In the first quarter of 2023, Alaunos
enhanced its manufacturing process to move from fresh to cryopreserved cell product enabling greater flexibility for patient scheduling and treatment. To date, the Company has manufactured multiple cryopreserved products with viability, purity and
TCR positivity comparable to our prior process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Completed full prepayment of amended loan and security agreement with Silicon Valley Bank (SVB):</B>
In May 2023, Alaunos fully prepaid the remaining amounts owed under its term loan with SVB, which was $11.0&nbsp;million as of March&nbsp;31, 2023. With no remaining obligations due to SVB, the restricted cash balance of $13.9&nbsp;million as of
March&nbsp;31, 2023, has also been released. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amended exclusive license agreement with Precigen, Inc.; Alaunos maintains exclusive rights to TCRs using
</B><B><I>Sleeping Beauty</I></B><B> targeting driver mutations: </B>In April 2023,<B> </B>Alaunos amended its exclusive license agreement with Precigen. Under the terms of the amended agreement, Alaunos maintains exclusive rights to TCRs using
<I>Sleeping Beauty</I> targeting driver mutations, while Precigen regains the rights to its <FONT STYLE="white-space:nowrap">CAR-T</FONT> and <FONT STYLE="white-space:nowrap">IL-12</FONT> assets. The amended agreement eliminated all commercial
sales-based royalties and milestone obligations, in alignment with Alaunos&#146; focus on its priority <FONT STYLE="white-space:nowrap">TCR-T</FONT> programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expanded infrastructure of hunTR</B><B><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP></B><B> TCR discovery platform to increase throughput;
expect to add three new TCRs in 2023: </B>In the first quarter of 2023, Alaunos significantly increased the throughput potential of its hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> TCR discovery platform to further accelerate TCR
discovery and validation. New lab equipment and advanced bioinformatics capabilities have multiplied the screening throughput while maintaining a high success rate of TCR discovery. The Company expects to add three new TCRs to its library,
potentially bringing the total number of unique TCRs to 15 by the end of 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Appointed Robert Hofmeister, PhD, MS, to Board of Directors: </B>In
March 2023,<B> </B>Alaunos appointed Robert J. Hofmeister, PhD, MS, to the Company&#146;s board of directors. Dr.&nbsp;Hofmeister brings deep expertise in the discovery and development of engineered <FONT STYLE="white-space:nowrap">T-cell</FONT>
receptor therapies as well as a background in cellular immunology and translational science. He is currently Chief Scientific Officer of a stealth early-stage biotechnology company and was most recently Chief Scientific Officer at TCR<SUP
STYLE="font-size:75%; vertical-align:top">2</SUP> Therapeutics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>First Quarter Ended March&nbsp;31, 2023, Financial Results </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development Expenses:</B> Research and development expenses were $6.5&nbsp;million for the first quarter of 2023, compared to $5.6&nbsp;million
for the first quarter of 2022, an increase of approximately 17%. The increase was primarily due to incremental manufacturing activities related to the <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 trial and hunTR<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> research efforts of $1.7&nbsp;million, partially offset by a $0.7&nbsp;million decrease in employee-related expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General and Administrative Expenses:</B> General and administrative expenses were $3.2&nbsp;million for the first quarter of 2023, compared to
$3.5&nbsp;million for the first quarter of 2022, a decrease of approximately 10%. The decrease was primarily due to lower professional fees of $0.2&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss:</B> Net loss was $10.0&nbsp;million, or $(0.04) per share, for the first quarter of 2023, compared to a net loss of $9.8&nbsp;million, or $(0.05)
per share, for the first quarter of 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash, Cash Equivalents and Restricted Cash:</B> As of March&nbsp;31, 2023, Alaunos had approximately
$37.4&nbsp;million in cash balances, which included restricted cash of approximately $13.9&nbsp;million. Based on current operating plans, the Company expects its operating outflows, excluding debt service costs, for 2023 to be between approximately
$35&nbsp;million and $40&nbsp;million. The Company expects to have sufficient cash resources to fund research and development programs and operations into the fourth quarter of 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Conference Call and Webcast </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alaunos will host a
conference call and webcast today, May&nbsp;10, 2023, at 9:00 a.m. ET. Participants may access the live webcast using the link <U>here</U> or by visiting the &#147;Investors&#148; section of the Alaunos website at <U>www.alaunos.com</U>. To
participate via telephone, please register in advance at <U>this link</U>. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the
<FONT STYLE="white-space:nowrap">dial-in</FONT> number along with a unique passcode and registrant ID that can be used to access the call. The event will be archived on the Company&#146;s website for approximately 30 days after the call. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics is a leader in the science of <FONT STYLE="white-space:nowrap">T-cell</FONT> receptor cell therapy working to revolutionize solid cancer
treatment and outcomes. The clinical-stage company&#146;s TCR <FONT STYLE="white-space:nowrap">T-cell</FONT> therapy <FONT STYLE="white-space:nowrap">(TCR-T)</FONT> is one of the most advanced TCR programs targeting driver mutations in solid tumors
with an ongoing Phase 1/2 trial of its <FONT STYLE="white-space:nowrap">TCR-T</FONT> product candidates across six solid cancers. Alaunos is powered by two proprietary platforms: its elegantly efficient
<FONT STYLE="white-space:nowrap">non-viral</FONT> Sleeping Beauty cell engineering platform; and its hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> discovery platform, which is expanding its industry-leading library of TCRs against
high-frequency driver mutations. Alaunos is a part of an ongoing collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), working to advance the science of TCR therapy. For more information,
visit&nbsp;<U>www.alaunos.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements Disclaimer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking
statements are statements that are not historical facts, and in some cases can be identified by terms such as &#147;may,&#148; &#147;will,&#148; &#147;could,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes&#148;
or other words or terms of similar meaning. These statements include, but are not limited to, statements regarding the Company&#146;s business and strategic plans, the anticipated outcome of preclinical and clinical studies by the Company or its
third-party collaborators, the Company&#146;s cash runway and forecasted operating cash flow, the Company&#146;s manufacturing capabilities and the timing of the Company&#146;s research and development programs, including the expected timeline for
enrolling and dosing patients, submitting and receiving approvals on INDs and similar regulatory submissions and the timing and forums for announcing data from the Company&#146;s clinical trials. Although the management team of Alaunos believes that
the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and
generally beyond the control of Alaunos, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties
include, among other things, changes in the Company&#146;s operating plans that may impact its cash expenditures; the uncertainties inherent in research and development, future clinical data and analysis, including whether any of Alaunos&#146;
product candidates will advance further in the preclinical research or clinical trial process, including receiving clearance from the U.S. Food and Drug Administration or equivalent foreign regulatory agencies to conduct clinical trials and whether
and when, if at all, they will receive final approval from the U.S. Food and Drug Administration or equivalent foreign regulatory agencies and for which indication; the strength and enforceability of Alaunos&#146; intellectual property rights; and
competition from other pharmaceutical and biotechnology companies; the impacts related to or resulting from recent bank failures and other economic and industry volatility; the potential delisting of the Company&#146;s common stock from the Nasdaq
Stock Market LLC, as well as risk factors discussed or identified in the public filings with the Securities and Exchange Commission made by Alaunos, including those risks and uncertainties listed in the most recent periodic report filed by Alaunos
with the Securities and Exchange Commission. Alaunos is providing this information as of the date of this press release, and Alaunos does not undertake any obligation to update or revise the information contained in this press release whether as a
result of new information, future events, or any other reason. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alex Lobo </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stern Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Alex.lobo@sternir.com </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Heather Anderson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6 Degrees PR </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>handerson@6degreespr.com </U></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Statement of Operations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In
thousands except per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Three Months Ended<br>March&nbsp;31<br>(Unaudited)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2022</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,085</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(853</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(683</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,788</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">239,679,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214,946,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Selected Balance Sheet Data </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In
thousands) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">March&nbsp;31,<br>2023<br>(Unaudited)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,<br>2022<br>(Audited)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital, excluding restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tcrt-20230510.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 12:04:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:tcrt="http://alaunos.com/20230510"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://alaunos.com/20230510"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tcrt-20230510_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tcrt-20230510_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tcrt-20230510_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 12:04:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tcrt-20230510_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 12:04:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tcrt-20230510.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g459099g27q68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g459099g27q68.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( #  S ,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /WXH ^$/VQOB#\2+S4_ '[/OP,U>_TGXJ?$!M3\47NIZ1J#
MZ7?:'X-\*V5Y>N3J,2%M/_M74K0VR2 @N+&:#C[0#7?@Z=-*IB*Z3I4[12:N
MG)Z;=>5:_._0X\5.I>%"B^6I+6ZTM%>?2[5CT_\ 9"^-$OQL^"V@ZSK$S-XV
M\,R2>#O'D$X$=XOB/1(XXFO[J MNBDU&Q:TO6!50LUQ<1 9@8#+%T?85I1CI
M3E[T.UGT^3T-,+5]K2BWI./NR]5_GN?4%<IT')67CSP=J'C+6?A[8^(=.N?&
MOA[2[#6];\-Q2,=3TS2=3*KI]_<Q% $MYRRA&#'.>E6Z<XPC4Y6H2;2?2ZW7
MR)4X\S@FN:*3:ZI=#K:@H* ,?Q!X@T3PIH>J^)?$FJ66B:!H5C/J6K:MJ$RV
M]E86-JADGN+B9N%15';))(5020"XQE*2A%.4I.R2WN*34$Y2?+&.K;Z)'+_#
MWXJ_#GXKZ??ZI\./&.A^,+#2KQ=/U&XT6Z^T+97CP)<QP7*,JO$SP2*ZDKAA
MNVDE6 NI2J46E4@X-JZ3[;$PJ4ZB;IR4E'30] K,LXMOB+X'C\=1_#)O$VEK
MX_ET0^(XO"AE8:L^A+(T+:FL.S;]E$J.N[=U4\5?LY^S]KROV:?+S=+]B.>"
MG[/F7/:_+UMW.TJ"SC/&WQ$\$?#>QTW4O'7B73/"]AK&LV?A[2[K5)6ABO=:
MOUE>RTV!E1MUS,L$Q52!GRSS5PISJ-JG%R<5=I=$MW\B)3A32<I**;25^_1'
M9U!9YYX/^+/PU\?:UXC\.>#/&N@>(=>\(7,EIXDT?3KQ9-1T>>&[N-/F6[M'
M59 D=[:SP/(BLBR)M9@64-I.C4I1C*<'&,OA;6CZ_D1&I3FY1A-2<=TMUT_0
M]#K,LXVY^(7@FR\<:=\-;KQ+ID'CS5M&G\0Z;X6>5AJMYHEL]Q%/J4,.S:UL
MCVEP"VX<PMQQ5JG/V;JJ+]G%\KETOT1'/!35/F2FU=1ZV74[+I[8_#&*C;RL
M7L?-'C3]JWX6>$+^XTFUGU/Q9?VDC0W/_"-V]O/I]O-&Q22%M5O+J"WGD5A@
M_9FG .02""!\'FOB)P]EM:>&ISJYC6IMQE]6C&5.,D[./M9SA"35M?9N:6S:
M:L?KO#W@KQGGF&I8VM3P^1X6M%2I_7YSA7G!I.,EAJ5.K5A%K5>V5)M:I--,
MD\$?M4_"WQC?V^D3W&I>$]2NI$AM(_$EO;V]C<SR,$C@BU2TN9[:*5F("K</
M!N.%4EB :RGQ#X>S.M##3G5RZO-J,%BHQC3E)NRBJL)3IIOHIN%WHKO0CB+P
M7XSR#"U<=2I4,ZPE!.51X"<YUJ<(J\IRP]6G2K2C%*[=*-3E6LK)-GTGT_#^
ME?='Y*<SXM\9^$O .C3>(?&OB71/"NB6Y"2:GKVI6NF6@D*LRPQRW4B":X94
M8K#'N=MIVJ<54(3FU&G%R?1)7_(F4HTU>4E%+JW8^:V_;Q_9,2[^Q_\ "XM(
M+;MGVA-%\5/8AAQC[:FA&';G^,,5[YQS75]0Q=OX+5NEXW^ZYA]<PRT]JM/)
M_G8^A?!/Q(\ ?$C3_P"U/ /C+PYXNL556EET'5K/4'MMQPJWEO!*9K*0X^Y/
M'&WM7-.E4I.U2#@UT:L;0G":O"2DO)_U8[%I8D98VEC1V^XC.BN^.NU206Q[
M"H_0O;R)![=N..Q!P1]01BC;R I:CJ-CH^GW^K:G=16.FZ7976HZC>SML@L[
M&Q@DN;NZF?\ @BBMXI)&/8(332;:BEJ]$O/9";44WLH_H?!7[(4$WQ2\:_%C
M]K+Q.JV\WQ#U6;P;\+[.]>-)M'^&?AFY%K')%&^/*>_O;2 2%=N9=-N7Y6YR
M>_%_N84<)#_ETN:;76;_ ,E^?D<>%7M)U,3+3G?+!=H1_P _T./CGB_9A_;6
M812Q6WPE_:FC!;RY%&GZ+\2X+G +!6$<+3ZQ?8R<+L\8_P!VR^6[?6<%_P!/
M<)]_)_P$O_)?,G_=L7II3Q'W*?\ P[_\F\C],NGMC\,8KS#O/AKP!_R?Y\?_
M /LB_P ,_P#T?;UW5/\ D7X?_KY,Y(?[Y6_Z]P/N6N$ZPH _/S]J[4-0^-/Q
M(^'7[(?A6[GAM?$,]KX^^-&HV+D/HWP]T.Z2XM-,FDC8B&YU&\B61$D /G+I
M><QW)KT,(E0I5,7):Q]RFN\WU^2_"YQ8ANK4IX6.TO>F^T5T^?\ D<IXHT^R
M_9 _:E\*^-=%M8-#^!GQ^MM.\">++"TC%MHOA+QMI4,=OH.IB)2(K2WD013;
MVQ^[NM=D/^K6K@WC,+*FWS5\/>47UE%[KS_X$29)87$1FERT:UHM=(R6S\O^
M'/TNZ?A_2O,.\_/>\_Y24Z3_ -F[W'_IVO*]%?\ (M?_ %^_1'$_]_7_ %Z_
M4_0BO..T_/K_ (**?\DX^$7_ &7[P'_Z2ZW7H9=_$K?]>I_H<6.^"E_U]C^I
M^@W?\?ZUYYVGXJ?#3X0>-M;E^.'QR^"E]+8?&SX6?M&_$N'3M->9VTKQ]X/>
M>VO=4\#ZE9EUC>2>2:YD@;<GF/+Y3,DGV>XL_:JUH1]A0K+]Q5HPN^L);*2?
MEU_X=/RJ=*;]K5I.U6E5G9=)1ZQ:_+_AFOT[^ 7QU\+_ !\\#0^*-#232M:T
MV?\ LCQIX0OF*:QX/\26X*WFEW\$BI)Y#21RM;7#1H)HU.52:*:&'S*]"6'G
MR/6+UC);2CT:_5=#OHUHUH<R]UQTE'K%]O\ (^;_ !=_RD=^%'_9 ?$7_IP\
M45TP_P"1;5_Z^K\HF$O]^I_]>W^;/3?VO/B%J'@[P'IWA[2;J2PO?&][=Z?<
MWL4AAFAT/3[>.75H895(:.2Y:ZLK9F4@B*>8#!8$?E'B5G5;+,GH8+#5'1JY
MM.=.4T[.-"G%.LHM:IS<Z=-M?8E+J[G[WX%\+87/>)<5F>-HQQ.'X=I4J].E
M*/-&6+K3E'#2G%IJ4:*IU:T4U;VD*;=TFG\^_ WX*_"S6?#=IXN^)_BW1H%U
M/S'T?PO_ ,)18:&L&GQ2-#%>:K(EY%=&>=HV>.WC>%8XO+9][2%8OC.$N%>'
ML5@:>99_F5""KW='"_6J=#EIIN*G5:G&IS3LW&"<5&'*WS.5H_J'B-X@\99?
MFU?(N#LDQ51X.T<5F']GUL6YUY14I4L-%TIT5"DI*,ZLHU)3J<RCRQBG.#XY
M?!KX6:)H$_BKX7>+]$NEL'B&L>%!XIT[6WELIY4@-[I#->2W9E@DDC,ML[3!
MHB[H4,6V2.+>%^'L'@YYAP_F="HJ#C[;!_6Z5=N$FH\]'WY5+P;3E!N2<+RB
MXN-I:>'''W&>89G2R7C'(L70>(4OJN8O+J^$4:L(N:I8E*E"@HU%&2IU8JFX
MU.6,U)3YH?2?[)7Q U'QC\/[O1=8N);S4O!-_!I,=Y.[23W&C75M]HTCSY&)
M:2:!8KJUWL<M':1%B6))^Z\-\YKYGDU3"XJ;J5\JJ1HJ<G>4J$X\U'F;U<H6
MG3N]7&$;W=V?DGC?POA>'^)Z&88"E'#X/B&C/$RI02C"GBJ=3DQ/)%)*,:CE
M3K<JT4ZLTDHI)?,?[0$W@;2OVR/"FL?M.0>=\$%^&Y3X8W.NVUU>_#^P\>17
MJ2:L-=M88I;>347B6?*W$;@B33#(#%&IC_5\.JCP<HX72OS^^EI/DMI;R]/,
M_"*W)'%1>(_@J/N7^%2ZW\_^ ?2FF_%W]BO5;1=.L?%WP!:P90BV$X\'V-KL
MQ@(;2^MH4"XXVE!7,Z.-B[N%5-=?>_0W57"-64J=NWNEKX=_!O\ 96E^(T'Q
M2^$=GX#_ .$OT>QOX9G^'?B6TDTE(M6C%K)=:AX=T+4GL$G6(S1Q2M;1A?M$
MAP7",BJ5L4J?LJKDH-JW/'73LVK^HX4L/S^TI*/-'^5Z:]TG;\#V3QW\,_#7
MQ"CACUY;I'M],UC2K>ZL#:P7MO;ZV+(7<EM=RVLLEM<+]@B\N2)DVEW)#9&,
M:=65+X>Z=GY7MI\S6=.,]]+)K[_^&-SP;X5L/ _AZS\-Z9=:C>VEG<:I=_;-
M7NA>ZG=76L:K>ZUJ%S>78CC\Z>74-0NI"VQ?O^U3.3G)R:2>FB5EHDE9>B'&
M*A%15VE???5W?YGR-^VAXIU?6],\!_LV^"KHP^,_C]XAAT/4)H<O)H?PZTR6
M.\\7ZQ<)&=T=N]K'Y!R,20)?J.5KLP4%%U,3->YAU=+O-Z17W_C8YL5)M0P\
M-)5G9^45\3_KS&I_P3P_9CC1$_X1_P 6ML14W'Q[XH0MM&"Q2*_1%+')(1%7
M). !Q1_:&*_FBK?W8_Y!]1PZ^R]/[TO\SS#XT_\ !/CX4V7PP\7ZG\)-+\3:
M?\1-$TM]<\+O/XLU[5ENKW1W34)--CM+^ZF3[7=VMO/;V\JJKQW$D$@8!"#K
M0S"K[6"JM.FW:7NI:/2^EMMWY&=7!4U3E[)-3BKQ]YO;6UF_DO,^I/V5/C/'
M\<_@KX5\87$R-XDLH?\ A'/&< &UX?%&C10Q7MP\1 ,27]N]IJ4:X^5-25>J
M''+BJ/U>O*"^'>/^%[?=M\CHPU7VU*,OM+27JM_OW^9Y-\/Q_P 9^?'_ -O@
MQ\,_P_?V^/Y5K4_Y%^'_ .ODS.'^^5O*$#[EP?0UPG6<?\0/&^A?#3P3XH\>
M>)KC[+H?A31KS6+]\JLDJ6L9,-G;AB ]W=7)AMH4_CEN(U_BJZ<)5)QIP7O2
M:2_KRW9,YQIPE.6BBKO^OP/R_P#@/I7[9-K?>+OCUX<^%OPMUW5_CU+8^*7U
M3QYXKU/3];TSPPR-)X>\/6%A:,G]GZ-#8O;M&CEGECCM6D_U2*GJ5W@K0P\J
MLXQP]XVA%6<NK;ZN_P"IY]%8I<U:-.#=;6\I--+HDNB2_0[SXR^$?VV/CE\/
MM8^'/C+X._ >+2=5:UN(=0T[QQK*ZIH^HV$ZW%EJFF27+R1QW<3*Z'>C*\4\
MT3 I*P.=&>"P]2-2%:K>/1Q5FNJ956.+K0=.=*FD^JD[IK9H]^_8Z^*^K^/_
M (;77@[QN)K;XI_!K59?AUX_L+QLW[W&CF2UTC6I_P#GK]NL;4H\X+"6YL+N
M124=2>?&4E2J*=/^%67/!]-=U\GTZ)HWPM1SI\D]*E%\LEZ;/YK\4SR?XA7-
MI\._V_OAEXX\77,6C>$_'WPDU/P)H6OWC?9]*_X2RTO[JX_L6[O9<16UU+%-
M9^4'90[7T*@_>V[4TZF7U:<%S3IU%)Q6_+:U[?UL9SM3QM.<O=C.#BGTNGM<
M_0_!';I_2O..T_.W]NS4+'QCJ/P$^"?AVYBU/XB:]\9?"WB2+0+1UGNM.\.Z
M/!J"W^M:M%$2VGV")=F423! \=I=.N5MW*^C@$Z:KUI+EIQIRC?S=K)>>GY=
MSAQC4G0I1UFZD7;LE>[?9'Z)=_QKSCN/@_\ 88X@_:5[8_:9^(GMC'V"N_'[
MX;_KS#]3CP>U?_K[/]"K\?\ X5^,/A+XYE_:K^ 5@T^NVL&/C/\ #BS5UL?B
M3X6@Q+>:M!:0#CQ):Q1^:\D:-(YC%TBO-%/%J2HUE4I?5*J3_P"?4Y.RIRZ7
M=F^7R2?;;55.DJ=7ZQ"3BH_Q(QCS.<5_+&\5S>;:77R?DOAOXD>%?CC^VE\%
M/&OA36/M6E>(/@%X@=Y=-EGTS6/#]U;7_B/[=X8U%([J1K74[:5L32#:9$EB
MDMV$,D;R8U<#BE@:]+$XNI34:T?<PZC2BU[MG[1J=9IKK&=/7HGH=E#,<'2Q
ME"IA<NI59^R?[S%RE7:>NU!.GAXM/I4IUM-.9[GTA^TUI>J>"/"^D^,O!FGZ
M7(]AJK6?B/4==T:Q\9:E;6>HQI'87D-YXJ@U%[&%-0B2&1HB@9KV'=P@Q^4\
M>X?$93E^&S/*Z%*3HU7#$U<10IXVK&%1)4YQGBXUW3BJB49.-KN<;[*W[MX0
M8S!\0YQC<@S_ !6(A&OAE5P-#!XJME5"I5H-NM2G2RZ>%C6G*A)U(*:E94I\
MNLG=_P"S]\9? OBKPU::-XPN/#.E^.M-\V&]EU.RT31HO$$ E9K74K%TMK>U
M:;[.T<4UO&%=9(6<)Y<BFJX,XHRC,,!3PN9SPN&S>A>,W5A0H+$1N^2K3:C"
MFY<K49PC:2E%OEY6F3XG\ \29)F];'Y#2Q^,X<Q7+*E'#U<7BI8*?*E4H5DZ
ME6LH<ZE.E5FW"4)*+ESQDC$_:9^)7PQLO!NI>$?#\?AC7?%NNI'9B;2;;3+W
M_A'[(S1R7=]<:A;1.MK>- CPP0I()M\WF85(R3R<>Y[D%+*Z^6X)87%YEBTH
M*5&-*?U>G=.=252*:C-Q3A"*ESWES648W/1\(.$N,*^?83.\SEF&6Y'ECE5Y
M<3/$4OKM51<:5&%"I*+J4HS:J59R@Z7+#DNY32.>_98^#VGZYX+U;Q9XACUJ
MPFUC5A%X9U'1]<UOP[J4.GZ7$T%Q>V]QI%[;^=!-J,EPBB994/V(D##<\7A[
MPS1Q>58G,<;&O1EB:W+A:E&O7PU6-.DN64XRHU(<T95')+F4D^2]K/7U/&;C
MO%9;Q!@<CRN6%Q%/ 8;FS"ABL'A,=0E7Q$E.%*=/$T:O).G0C3E+V;A)>ULW
M=:>^^&[SX8ZIKWC'X.:W\2=-^*FKZ/-IDFH> O'O_"-ZWJ^AK/8_;$B:.72X
M'UY'M[B"1WE6\DMB521T>0@_JV6Y;C<LIS<\RQ>/H5&G1EB?9N=)*ZE%5J=.
MG.HI.VM7FDK:-W9_/N=YUE^=5*#HY'E^3XFC&2Q"P'MX4L0VXN$WAJU:M3HN
M"35L.H0?-K%65K-]^R_^SKJ.?M?P2^&C;NOE>$=(M3SZ&UMHR/PKU5BL1':O
M-6_O/]3P'AZ'_/J&G]U'PS^TG\,?A1^SMXW^"'C#X!6%MX'^,VJ?$[P[H=OX
M,\,WUV;?Q;X2U:X>SUV+5/#YN)1#I[.]I:&5%ACD-ZRE9)(TDMN[#5:N(IUX
M5WST8P;YI?9DM59]^OR^_DKTZ>'G1E17)5<TE%=8[.Z[=#]7#Q^']*\H]$*
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M*K"#=[4H+0D\#_L4P6=]#=>/_$]OJ5A;R*YT'PW;W-E!>!>?*O-5NBLR6S$
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<<VI*:IQ]I\:6OZ7MI>V]M+['I-9&@4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140443270425280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001107421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 10,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Alaunos Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1475642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8030 El Rio Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">355-4099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCRT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d459099d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcrt-20230510.xsd" xlink:type="simple"/>
    <context id="duration_2023-05-10_to_2023-05-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2023-05-10</startDate>
            <endDate>2023-05-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-05-10_to_2023-05-10">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-05-10_to_2023-05-10"
      id="Hidden_dei_EntityCentralIndexKey">0001107421</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-05-10_to_2023-05-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-05-10_to_2023-05-10">2023-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-05-10_to_2023-05-10">Alaunos Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-05-10_to_2023-05-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-05-10_to_2023-05-10">001-33038</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-05-10_to_2023-05-10">84-1475642</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-05-10_to_2023-05-10">8030 El Rio Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-05-10_to_2023-05-10">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-05-10_to_2023-05-10">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-05-10_to_2023-05-10">77054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-05-10_to_2023-05-10">(346)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-05-10_to_2023-05-10">355-4099</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-05-10_to_2023-05-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-05-10_to_2023-05-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-05-10_to_2023-05-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-05-10_to_2023-05-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-05-10_to_2023-05-10">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-10_to_2023-05-10">TCRT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-10_to_2023-05-10">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-05-10_to_2023-05-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MWR-PP.WB@[_$"#@OCXZ.7DD9[Z3ZJA/&#'G+4J$G3F),?N.Z.DI81O65S)F
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M:V/!PT>7'Q&(00TQ. ]BP127MLQC I.EE0=7>B_NKNH>UF3#<T;MA6VYK6]
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( !TYJE;\W+))[@   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( !TYJE:97)PC$ 8  )PG   3
M      "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ '3FJ
M5MOLC_=.!   D1   !@              ("!#0@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( !TYJE:?H!OPL0(  .(,   -
M      "  9$,  !X;"]S='EL97,N>&UL4$L! A0#%     @ '3FJ5I>*NQS
M    $P(   L              ( !;0\  %]R96QS+RYR96QS4$L! A0#%
M  @ '3FJ5APX9>H_ 0  / (   \              ( !5A   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( !TYJE8D'INBK0   /@!   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M !TYJE9ED'F2&0$  ,\#   3              "  :<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  /$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d459099d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d459099d8k.htm">d459099d8k.htm</File>
    <File>d459099dex991.htm</File>
    <File>tcrt-20230510.xsd</File>
    <File>tcrt-20230510_lab.xml</File>
    <File>tcrt-20230510_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d459099d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d459099d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tcrt-20230510_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcrt-20230510_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tcrt-20230510.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tcrt",
   "nsuri": "http://alaunos.com/20230510",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d459099d8k.htm",
      "contextRef": "duration_2023-05-10_to_2023-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d459099d8k.htm",
      "contextRef": "duration_2023-05-10_to_2023-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alaunos.com//20230510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-140010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-140010-xbrl.zip
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M,/*A,>R0;C=&99+&&4E"&??-6,?"#*T<L5^W2R@1S-_W6#H87*_1:<6@6VA
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M'D2H]MLE0D4FZ-Y?'!TO+BT7OT@2E<*2=J8)HTC)T46?XD@XXIBBZWHMD>#
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M+FAT;5!+ 0(4 Q0    ( !TYJE9"[4?O.P,  #X+   1              "
M 2@G  !T8W)T+3(P,C,P-3$P+GAS9%!+ 0(4 Q0    ( !TYJE9,H;?T7 8
M +]#   5              "  9(J  !T8W)T+3(P,C,P-3$P7VQA8BYX;6Q0
M2P$"% ,4    "  =.:I6U_VU@[,$  !S*@  %0              @ $A,0
K=&-R="TR,#(S,#4Q,%]P<F4N>&UL4$L%!@     %  4 0 $   <V      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
